The receptor for the salt retaining hormone aldosterone, the mineralocorticoid receptor, is present in normal breast. Our recent large study identified a potential inhibitory role for the mineralocorticoid receptor in breast cancer. These findings raise exciting possibilities with respect to the regulation of cell growth. The proposed studies will explore this unchartered territory with a view to identifying and exploring a range of novel possible targets for the treatment of breast cancer.
Prof Peter Fuller, Dr Ann Drummond, Dr Morag Young, Prof Christine Clarke
Cancer Council Research Grant - Girls Night In
Hudson Institute of Medical Research
$100,000 per annum